Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 | Nature
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
Information for Pharmacists: Everything You Need to Know about the COVID Vaccines
What is the recommended interval between doses? - MOH FAQ - AskGov
Introduction of shorter interval between vaccine doses | Department of Health
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table
expert comment on whether giving two doses of COVID vaccine separated by a longer period is sensible | Science Media Centre
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) - The Lancet
COVID-19 Vaccine Boosters vs. Third Doses: Frequently Asked Questions - Anne Arundel County Department of Health
Covid vaccines slash risk of infection, illness and death, UK studies find | Financial Times
2021-07-07-grafik-impfstoffe-data.png
Evaluation of COVID-19 vaccination strategies with a delayed second dose | PLOS Biology
Information for Pharmacists: Everything You Need to Know about the COVID Vaccines
Researchers urge delaying Pfizer vaccine's second dose as first highly effective | Reuters
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science
What Does a Multi-Dose Series Mean for the COVID-19 Vaccination Effort? | KFF
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
